"Effective today, and still effective in ten years."
Antimicrobial supply is a stewardship question before it is a commercial one.
This category carries the portfolio’s widest span, from first-line oral antibiotics to reserve hospital injectables. VAIS™ weighs resistance-profile data and national treatment guidelines alongside manufacturing quality, because a molecule that undermines local stewardship policy is the wrong molecule however it prices.
Category Focus
Cold-chain and reserve-antibiotic candidates are screened against the destination market’s stewardship policy before VAIS™ will shortlist them.
Products in This Category
Filter by Product Type
Development StageSourcingDossier ReviewDossier ScreeningProduct SubmissionApprovalLaunch